Abiopharma

News list

Rolke James 🔴 sold 10.1K shares of REVELATION BIOSCIENCES, INC. (REVB) at $1.13 Transaction Date: Apr 30, 2026 | Filing ID: 201769

Full text

News bot May 1, 2026, 9:33 p.m.
🔍 Rolke James (Executive)

Company: REVELATION BIOSCIENCES, INC. (REVB)

Report Date: 2026-04-30
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 10,115
Detailed Transactions and Holdings:
- Sold 10,115 shares of Common Stock at $1.13 per share (Direct)
  Date: 2026-04-30 | Code: F | equity_swap_involved: false | shares_owned_after: 214,738.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Represents shares sold by the issuer on behalf of the reporting person solely to satisfy required tax withholding obligations arising upon the vesting of restricted stock awards. The transaction was mandatory and the reporting person did not exercise investment discretion with respect to the sale.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.14, inclusive. The reporting person undertakes to provide to Revelation Biosciences, Inc. (REVB), any security holder of REVB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.